US Patent Issued to MINDSET PHARMA on April 21 for "Indole derivatives as serotonergic agents useful for the treatment of disorders related thereto" (Canadian Inventor)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,543, issued on April 21, was assigned to MINDSET PHARMA INC. (St-Laurent, Canada).

"Indole derivatives as serotonergic agents useful for the treatment of disorders related thereto" was invented by Abdelmalik Slassi (Ontario, Canada).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to indole derivatives of general Formula (I), to processes for their preparation, to compositions including indole derivatives of general Formula (I), and to their use in activation of a serotonin receptors in a cell, as well as to treating diseases, disorders, or conditions by activation of a serotonin receptors in a cell. The diseases, disord...